Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia. | Front Oncol | 2022 | 37078002 | PubTator, text mining | PubMed |
| Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya. | PLOS Glob Public Health | 2022 | 36962187 | PubTator, text mining | PubMed |
| Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome. | Cancer Res Commun | 2022 | 36923555 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen Selectivity. | Cancer Res Commun | 2022 | 36860694 | PubTator, text mining | PubMed |
| NK cell-derived exosomes enhance the anti-tumor effects against ovarian cancer by delivering cisplatin and reactivating NK cell functions. | Front Immunol | 2022 | 36741396 | PubTator, text mining | PubMed |
| Identification and classification of distinct surface markers of T regulatory cells. | Front Immunol | 2022 | 36741366 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma. | Front Oncol | 2022 | 36733364 | PubTator, text mining | PubMed |
| A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. | Front Oncol | 2022 | 36713541 | PubTator, text mining | PubMed |
| A signature-based classification of lung adenocarcinoma that stratifies tumor immunity. | Front Oncol | 2022 | 36713530 | PubTator, text mining | PubMed |
| Integrated analysis of transcription factor-mRNA-miRNA regulatory network related to immune characteristics in medullary thyroid carcinoma. | Front Immunol | 2022 | 36713370 | PubTator, text mining | PubMed |
| Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. | Front Genet | 2022 | 36712869 | PubTator, text mining | PubMed |
| Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO-positive acute myeloid leukemia. | Front Pharmacol | 2022 | 36712661 | PubTator, text mining | PubMed |
| Case Report: Whole genome sequencing identifies CCDC88C as a novel JAK2 fusion partner in pediatric T-cell acute lymphoblastic leukemia. | Front Pediatr | 2022 | 36704135 | PubTator, text mining | PubMed |
| Systematic review of transcriptome and microRNAome associations with gestational diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | 36704034 | PubTator, text mining | PubMed |
| Natural biomolecules and derivatives as anticancer immunomodulatory agents. | Front Immunol | 2022 | 36700235 | PubTator, text mining | PubMed |
| Contribution of natural killer cells in innate immunity against colorectal cancer. | Front Oncol | 2022 | 36686835 | PubTator, text mining | PubMed |
| Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network. | Front Genet | 2022 | 36685822 | PubTator, text mining | PubMed |
| Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis. | Front Immunol | 2022 | 36685512 | PubTator, text mining | PubMed |
| Shared gene characteristics and molecular mechanisms of macrophages M1 polarization in calcified aortic valve disease. | Front Cardiovasc Med | 2022 | 36684607 | PubTator, text mining | PubMed |
| Trypanosoma cruzi-specific CD8+ T cells and other immunological hallmarks in chronic Chagas cardiomyopathy: Two decades of research. | Front Cell Infect Microbiol | 2022 | 36683674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=30